ImmunologybioRxiv
One mucosal administration of a live attenuated recombinant COVID-19 vaccine protects non-human primates from SARS-CoV-2
M. F. Tioni, R. Jordan, A. Silva Pena…·R. S. Tang
This study shows that a single mucosal dose of the live attenuated RSV-based vaccine MV-014-212 protects non-human primates from SARS-CoV-2 infection by reducing viral shedding and inducing neutralizing antibodies.
DOI 10.1038/s41541-022-00509-6